Inventor · disambiguated record
Fei Shen
Also filed as: SHEN FEI
8 granted patents·11 pending applications·5 citations·filing 2010–2025
77Inventor score
Top patents by PatentIndex Score
19 records- 0184US12378326B2Anti-CD28 x anti-PSMA antibodiesXENCOR INC·Filed 2024·Granted Aug 5, 2025·0 cites·30 claims
- 0281US2025388704A1Anti-cd28 x anti-psma antibodiesXENCOR INC·Filed 2025·Application pending·0 cites
- 0379US12365743B2Anti-CD28 x anti-PSMA antibodiesXENCOR INC·Filed 2023·Granted Jul 22, 2025·0 cites·1 claims
- 0478US2024409544A1SUBSTITUTED PYRROLO[1,2-a]QUINOXALIN-4(5H)-ONES AS CX3CR1 ANTAGONISTSUNIV DREXEL·Filed 2024·Application pending·0 cites
- 0576US8404711B25-HT4 receptor agonist compounds for treatment of cognitive disordersBEATTIE DAVID·Filed 2010·Granted Mar 26, 2013·4 cites·4 claims
- 0676US2023322961A1Anti-cd28 x anti-psma antibodiesXENCOR INC·Filed 2023·Application pending·0 cites
- 0774US12152036B2Substituted pyrrolo[1,2-α]quinoxalin-4(5H)-ones as CX3CR1 antagonistsUNIV DREXEL·Filed 2022·Granted Nov 26, 2024·0 cites·32 claims
- 0870US2024124583A1Proteins Comprising Kallikrein Related Paptidase 2 Antigen Binding Domains And Their UsesJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 0966US10517933B2Method of treating androgen receptor negative prostate tumors and their metastasesUNIV DREXEL·Filed 2016·Granted Dec 31, 2019·1 cites·6 claims
- 1065US11267817B2Substituted pyrrolo[1,2-a]quinoxalin-4(5H)-ones as CX3CR1 antagonistsUNIV DREXEL·Filed 2018·Granted Mar 8, 2022·0 cites·63 claims
- 1161US12077585B2Proteins comprising kallikrein related peptidase 2 antigen binding domains and their usesJANSSEN BIOTECH INC·Filed 2020·Granted Sep 3, 2024·0 cites·96 claims
- 1261US2025099635A1Iimmunoconjugates comprising kallikrein related peptidase 2 antigen binding domains and their usesJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 1355US2025325718A1Immunoconjugates comprising kallikrein related peptidase 2 antigen binding domains and their usesJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 1451US2022356266A1Biosynthetic glycoprotein populationsJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 1551US2023193269A1Oligonucleotides for splice modulation of card9BOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 1648US12071466B2Anti-human kallikrein-2 (hK2) chimeric antigen receptor (CAR) and methods of use thereofJANSSEN BIOTECH INC·Filed 2020·Granted Aug 27, 2024·0 cites·35 claims
- 1746US2014057939A15-ht4 receptor agonist compounds for treatment of cognitive disordersBEATTIE DAVID·Filed 2013·Application pending·0 cites
- 1845US2022042011A1Antisense oligonucleotides targeting card9HOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 1934US2011263631A1Combination of a serotonin and norepinephrine reuptake inhibitor and an opioid agonist for the treatment of painMARTIN WILLIAM J·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fei Shen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →